Showing results (161-170 of 266) with videos related to

Sort By:
Pageof 27
JCO Precision Oncology|January 20, 2022
Clinical Pan-Cancer Assessment of Mismatch Repair Deficiency Using Tumor-Only, Targeted Next-Generation SequencingAdem Albayrak, Ana C Garrido-Castro, Marios Giannakis, et al.
JCO Precision Oncology|May 14, 2026
Clinical Liquid Biopsy Testing for Detection of Actionable Genomic Alterations in Children and Young Adults With Advanced Solid Tumors on the GAIN StudyHolly J Roberts, Hannah Comeau, Kelly Klega, et al.
Cancer Medicine|March 22, 2021
Retrospective evaluation of single patient investigational new drug (IND) requests in pediatric oncologyDavid S Shulman, Lulla V Kiwinda, Stacey Edwards, et al.
Cancer Research Communications|October 3, 2022
BRCA1-associated RING domain-1 (BARD1) loss and GBP1 expression enhance sensitivity to DNA damage in Ewing sarcomaLisa M Maurer, Jessica D Daley, Elina Mukherjee, et al.
The Lancet. Oncology|April 3, 2018
Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 studyTheodore W Laetsch, Steven G DuBois, Leo Mascarenhas, et al.
Science (New York, N.Y.)|January 2, 2025
Rare germline structural variants increase risk for pediatric solid tumorsRiaz Gillani, Ryan L Collins, Jett Crowdis, et al.
Cardio-Oncology (London, England)|March 11, 2020
Effects of dexrazoxane on doxorubicin-related cardiotoxicity and second malignant neoplasms in children with osteosarcoma: a report from the Children's Oncology GroupLisa M Kopp, Richard B Womer, Cindy L Schwartz, et al.
JCO Oncology Advances|May 14, 2026
PEPN1924, A Phase II Study of Trastuzumab Deruxtecan in Patients With Recurrent Human Epidermal Growth Factor Receptor 2+ Osteosarcoma: A Children's Oncology Group Pediatric Early-Phase Clinical Trial Network StudyDamon R Reed, Katherine A Janeway, Charles G Minard, et al.
International Journal of Cancer|June 21, 2017
A phase II trial evaluating the feasibility of adding bevacizumab to standard osteosarcoma therapyFariba Navid, Victor M Santana, Michael Neel, et al.
Cancers|September 13, 2025
ESFT13: A Phase II Study Evaluating the Addition of Window and Maintenance Therapy to a Standard Chemotherapy Backbone for the Treatment of High-Risk Ewing SarcomaJessica Gartrell, Fariba Navid, Xiaomeng Yuan, et al.
Pageof 27